פלואד

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE VIRUS; A/HONG KONG/4801/2014 (H3N2) - LIKE VIRUS; B/BRISBANE/60/2008 - LIKE VIRUS

Disponibbli minn:

NEOPHARM SCIENTIFIC LTD

Kodiċi ATC:

J06BB07

Għamla farmaċewtika:

תרחיף להזרקה

Kompożizzjoni:

B/BRISBANE/60/2008 - LIKE VIRUS 15 MCG / 0.5 ML; A/HONG KONG/4801/2014 (H3N2) - LIKE VIRUS 15 MCG / 0.5 ML; A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE VIRUS 15 MCG / 0.5 ML

Rotta amministrattiva:

תוך-שרירי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

SEQIRUS VACCINES LTD, UK

Grupp terapewtiku:

VACCINIA IMMUNOGLOBULIN

Żona terapewtika:

VACCINIA IMMUNOGLOBULIN

Indikazzjonijiet terapewtiċi:

Active immunisation against influenza in theelderly (65 years of age and over), especially for those with an infreased risk of associated complications (i.e. patients affected by underlying chronic diseases including diabetes, cardiovascular and respiratory diseases).

Data ta 'l-awtorizzazzjoni:

2015-12-31